TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PharmInfo i Uppsala AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
134
|
307
|
530 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
103
|
166
|
279 |
| EBITDA |
126
|
188
|
347 |
| Total assets |
1,869
|
2,007
|
2,197 |
| Current assets |
1,650
|
1,993
|
2,146 |
| Current liabilities |
64
|
132
|
153 |
| Equity capital |
1,702
|
1,746
|
1,895 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
91.1%
|
87.0%
|
86.3% |
| Turnover per employee |
134
|
307
|
530 |
| Profit as a percentage of turnover |
76.9%
|
54.1%
|
52.6% |
| Return on assets (ROA) |
5.5%
|
8.3%
|
12.7% |
| Current ratio |
2578.1%
|
1509.8%
|
1402.6% |
| Return on equity (ROE) |
6.1%
|
9.5%
|
14.7% |
| Change turnover |
-175
|
-180
|
530 |
| Change turnover % |
-57%
|
-37% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.